▶ 調査レポート

卵胞刺激ホルモンのグローバル市場2021

• 英文タイトル:Global Follicle Stimulating Hormone Sales Market Report 2021

QYResearchが調査・発行した産業分析レポートです。卵胞刺激ホルモンのグローバル市場2021 / Global Follicle Stimulating Hormone Sales Market Report 2021 / QAF27692資料のイメージです。• レポートコード:QAF27692
• 出版社/出版日:QYResearch / 2021年5月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(即日納品)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界の卵胞刺激ホルモン市場について種類別(組換えFSH、尿中FSH)、用途別(不妊治療、生殖補助医療)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・卵胞刺激ホルモン市場の概要
・世界の主要地域別卵胞刺激ホルモン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の卵胞刺激ホルモン市場規模2016-2021:種類別(組換えFSH、尿中FSH)
・世界の卵胞刺激ホルモン市場予測2012-2027:種類別(組換えFSH、尿中FSH)
・世界の卵胞刺激ホルモン市場規模2016-2021:用途別(不妊治療、生殖補助医療)
・世界の卵胞刺激ホルモン市場予測2012-2027:用途別(不妊治療、生殖補助医療)
・卵胞刺激ホルモンのアメリカ市場規模と予測2016-2021
・卵胞刺激ホルモンのヨーロッパ市場規模と予測2016-2021
・卵胞刺激ホルモンの中国市場規模と予測2016-2021
・卵胞刺激ホルモンの日本市場規模と予測2016-2021
・卵胞刺激ホルモンの東南アジア市場規模と予測2016-2021
・卵胞刺激ホルモンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Merck Serono、MSD、IBSA、Ferring、Livzon、Techwell、GenSci、Gedeon Richter、Teva)
・卵胞刺激ホルモンの製造コスト分析
・販売チャネル、流通業者、顧客
・卵胞刺激ホルモンの市場動向・機会・課題
・調査の結論

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

Market Analysis and Insights: Global Follicle Stimulating Hormone Market
The global Follicle Stimulating Hormone market was valued at US$ 1275.1 in 2020 and will reach US$ 1504.9 million by the end of 2027, growing at a CAGR of 2.8% during 2022-2027.

Global Follicle Stimulating Hormone Scope and Market Size
The global Follicle Stimulating Hormone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Follicle Stimulating Hormone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Recombinant FSH
Urinary FSH

Segment by Application
Infertility Treatment
Assisted Reproductive Technology

The Follicle Stimulating Hormone market is analysed and market size information is provided by regions (countries). Segment by Application, the Follicle Stimulating Hormone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva

レポート目次

1 Follicle Stimulating Hormone Market Overview
1.1 Follicle Stimulating Hormone Product Scope
1.2 Follicle Stimulating Hormone Segment by Type
1.2.1 Global Follicle Stimulating Hormone Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone Segment by Application
1.3.1 Global Follicle Stimulating Hormone Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Follicle Stimulating Hormone Market Estimates and Forecasts (2016-2027)
1.4.1 Global Follicle Stimulating Hormone Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Follicle Stimulating Hormone Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Follicle Stimulating Hormone Price Trends (2016-2027)

2 Follicle Stimulating Hormone Estimates and Forecasts by Region
2.1 Global Follicle Stimulating Hormone Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Follicle Stimulating Hormone Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
2.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
2.3 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Follicle Stimulating Hormone Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Follicle Stimulating Hormone Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Follicle Stimulating Hormone Estimates and Projections (2016-2027)
2.4.2 Europe Follicle Stimulating Hormone Estimates and Projections (2016-2027)
2.4.3 China Follicle Stimulating Hormone Estimates and Projections (2016-2027)
2.4.4 Japan Follicle Stimulating Hormone Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Follicle Stimulating Hormone Estimates and Projections (2016-2027)
2.4.6 India Follicle Stimulating Hormone Estimates and Projections (2016-2027)
3 Global Follicle Stimulating Hormone Competition Landscape by Players
3.1 Global Top Follicle Stimulating Hormone Players by Sales (2016-2021)
3.2 Global Top Follicle Stimulating Hormone Players by Revenue (2016-2021)
3.3 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2020)
3.4 Global Follicle Stimulating Hormone Average Price by Company (2016-2021)
3.5 Manufacturers Follicle Stimulating Hormone Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Follicle Stimulating Hormone Market Size by Type
4.1 Global Follicle Stimulating Hormone Historic Market Review by Type (2016-2021)
4.1.1 Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
4.1.2 Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2021)
4.1.3 Global Follicle Stimulating Hormone Price by Type (2016-2021)
4.2 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Follicle Stimulating Hormone Sales Forecast by Type (2022-2027)
4.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Type (2022-2027)
4.2.3 Global Follicle Stimulating Hormone Price Forecast by Type (2022-2027)
5 Global Follicle Stimulating Hormone Market Size by Application
5.1 Global Follicle Stimulating Hormone Historic Market Review by Application (2016-2021)
5.1.1 Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
5.1.2 Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2021)
5.1.3 Global Follicle Stimulating Hormone Price by Application (2016-2021)
5.2 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Follicle Stimulating Hormone Sales Forecast by Application (2022-2027)
5.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Application (2022-2027)
5.2.3 Global Follicle Stimulating Hormone Price Forecast by Application (2022-2027)

6 North America Follicle Stimulating Hormone Market Facts & Figures
6.1 North America Follicle Stimulating Hormone Sales by Company
6.1.1 North America Follicle Stimulating Hormone Sales by Company (2016-2021)
6.1.2 North America Follicle Stimulating Hormone Revenue by Company (2016-2021)
6.2 North America Follicle Stimulating Hormone Sales Breakdown by Type
6.2.1 North America Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
6.2.2 North America Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
6.3 North America Follicle Stimulating Hormone Sales Breakdown by Application
6.3.1 North America Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
6.3.2 North America Follicle Stimulating Hormone Sales Breakdown by Application (2022-2027)

7 Europe Follicle Stimulating Hormone Market Facts & Figures
7.1 Europe Follicle Stimulating Hormone Sales by Company
7.1.1 Europe Follicle Stimulating Hormone Sales by Company (2016-2021)
7.1.2 Europe Follicle Stimulating Hormone Revenue by Company (2016-2021)
7.2 Europe Follicle Stimulating Hormone Sales Breakdown by Type
7.2.1 Europe Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
7.2.2 Europe Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
7.3 Europe Follicle Stimulating Hormone Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Follicle Stimulating Hormone Market Facts & Figures
8.1 China Follicle Stimulating Hormone Sales by Company
8.1.1 China Follicle Stimulating Hormone Sales by Company (2016-2021)
8.1.2 China Follicle Stimulating Hormone Revenue by Company (2016-2021)
8.2 China Follicle Stimulating Hormone Sales Breakdown by Type
8.2.1 China Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
8.2.2 China Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
8.3 China Follicle Stimulating Hormone Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Follicle Stimulating Hormone Market Facts & Figures
9.1 Japan Follicle Stimulating Hormone Sales by Company
9.1.1 Japan Follicle Stimulating Hormone Sales by Company (2016-2021)
9.1.2 Japan Follicle Stimulating Hormone Revenue by Company (2016-2021)
9.2 Japan Follicle Stimulating Hormone Sales Breakdown by Type
9.2.1 Japan Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
9.2.2 Japan Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
9.3 Japan Follicle Stimulating Hormone Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Follicle Stimulating Hormone Market Facts & Figures
10.1 Southeast Asia Follicle Stimulating Hormone Sales by Company
10.1.1 Southeast Asia Follicle Stimulating Hormone Sales by Company (2016-2021)
10.1.2 Southeast Asia Follicle Stimulating Hormone Revenue by Company (2016-2021)
10.2 Southeast Asia Follicle Stimulating Hormone Sales Breakdown by Type
10.2.1 Southeast Asia Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Follicle Stimulating Hormone Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Follicle Stimulating Hormone Market Facts & Figures
11.1 India Follicle Stimulating Hormone Sales by Company
11.1.1 India Follicle Stimulating Hormone Sales by Company (2016-2021)
11.1.2 India Follicle Stimulating Hormone Revenue by Company (2016-2021)
11.2 India Follicle Stimulating Hormone Sales Breakdown by Type
11.2.1 India Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
11.2.2 India Follicle Stimulating Hormone Sales Breakdown by Type (2022-2027)
11.3 India Follicle Stimulating Hormone Sales Breakdown by Application
11.3.1 India Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
11.3.2 India Follicle Stimulating Hormone Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Follicle Stimulating Hormone Business
12.1 Merck Serono
12.1.1 Merck Serono Corporation Information
12.1.2 Merck Serono Business Overview
12.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Serono Follicle Stimulating Hormone Products Offered
12.1.5 Merck Serono Recent Development
12.2 MSD
12.2.1 MSD Corporation Information
12.2.2 MSD Business Overview
12.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.2.4 MSD Follicle Stimulating Hormone Products Offered
12.2.5 MSD Recent Development
12.3 IBSA
12.3.1 IBSA Corporation Information
12.3.2 IBSA Business Overview
12.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.3.4 IBSA Follicle Stimulating Hormone Products Offered
12.3.5 IBSA Recent Development
12.4 Ferring
12.4.1 Ferring Corporation Information
12.4.2 Ferring Business Overview
12.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ferring Follicle Stimulating Hormone Products Offered
12.4.5 Ferring Recent Development
12.5 Livzon
12.5.1 Livzon Corporation Information
12.5.2 Livzon Business Overview
12.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Livzon Follicle Stimulating Hormone Products Offered
12.5.5 Livzon Recent Development
12.6 Techwell
12.6.1 Techwell Corporation Information
12.6.2 Techwell Business Overview
12.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Techwell Follicle Stimulating Hormone Products Offered
12.6.5 Techwell Recent Development
12.7 GenSci
12.7.1 GenSci Corporation Information
12.7.2 GenSci Business Overview
12.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GenSci Follicle Stimulating Hormone Products Offered
12.7.5 GenSci Recent Development
12.8 Gedeon Richter
12.8.1 Gedeon Richter Corporation Information
12.8.2 Gedeon Richter Business Overview
12.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Gedeon Richter Follicle Stimulating Hormone Products Offered
12.8.5 Gedeon Richter Recent Development
12.9 Teva
12.9.1 Teva Corporation Information
12.9.2 Teva Business Overview
12.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Follicle Stimulating Hormone Products Offered
12.9.5 Teva Recent Development

13 Follicle Stimulating Hormone Manufacturing Cost Analysis
13.1 Follicle Stimulating Hormone Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Follicle Stimulating Hormone
13.4 Follicle Stimulating Hormone Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Follicle Stimulating Hormone Distributors List
14.3 Follicle Stimulating Hormone Customers

15 Market Dynamics
15.1 Follicle Stimulating Hormone Market Trends
15.2 Follicle Stimulating Hormone Drivers
15.3 Follicle Stimulating Hormone Market Challenges
15.4 Follicle Stimulating Hormone Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Follicle Stimulating Hormone Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Follicle Stimulating Hormone Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Follicle Stimulating Hormone Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Follicle Stimulating Hormone Sales (K Doses) by Region (2016-2021)
Table 5. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 6. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Follicle Stimulating Hormone Revenue Share by Region (2016-2021)
Table 8. Global Follicle Stimulating Hormone Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Follicle Stimulating Hormone Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Follicle Stimulating Hormone Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Follicle Stimulating Hormone Revenue Share Forecast by Region (2022-2027)
Table 12. Global Follicle Stimulating Hormone Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Follicle Stimulating Hormone Sales Share by Company (2016-2021)
Table 14. Global Follicle Stimulating Hormone Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Follicle Stimulating Hormone Revenue Share by Company (2016-2021)
Table 16. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle Stimulating Hormone as of 2020)
Table 17. Global Follicle Stimulating Hormone Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Follicle Stimulating Hormone Manufacturing Sites and Area Served
Table 19. Manufacturers Follicle Stimulating Hormone Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 22. Global Follicle Stimulating Hormone Sales Share by Type (2016-2021)
Table 23. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2016-2021)
Table 25. Global Follicle Stimulating Hormone Sales Share by Type (2022-2027)
Table 26. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Follicle Stimulating Hormone Revenue Share by Type (2022-2027)
Table 28. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2022-2027)
Table 29. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2016-2021)
Table 30. Global Follicle Stimulating Hormone Sales Share by Application (2016-2021)
Table 31. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2016-2021)
Table 33. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2022-2027)
Table 34. Global Follicle Stimulating Hormone Sales Share by Application (2022-2027)
Table 35. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Follicle Stimulating Hormone Revenue Share by Application (2022-2027)
Table 37. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2022-2027)
Table 38. North America Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 39. North America Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 40. North America Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 42. North America Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 43. North America Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 44. North America Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 45. North America Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 46. North America Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 47. North America Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 48. North America Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 49. North America Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 50. Europe Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 51. Europe Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 52. Europe Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 54. Europe Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 56. Europe Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 58. Europe Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 60. Europe Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 62. China Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 63. China Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 64. China Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 66. China Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 67. China Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 68. China Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 69. China Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 70. China Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 71. China Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 72. China Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 73. China Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 74. Japan Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 75. Japan Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 76. Japan Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 78. Japan Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 80. Japan Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 82. Japan Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 84. Japan Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 98. India Follicle Stimulating Hormone Sales (K Doses) by Company (2016-2021)
Table 99. India Follicle Stimulating Hormone Sales Market Share by Company (2016-2021)
Table 100. India Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Follicle Stimulating Hormone Revenue Market Share by Company (2016-2021)
Table 102. India Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 103. India Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 104. India Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 105. India Follicle Stimulating Hormone Sales Market Share by Type (2022-2027)
Table 106. India Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 107. India Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 108. India Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 109. India Follicle Stimulating Hormone Sales Market Share by Application (2022-2027)
Table 110. Merck Serono Corporation Information
Table 111. Merck Serono Description and Business Overview
Table 112. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Merck Serono Follicle Stimulating Hormone Product
Table 114. Merck Serono Recent Development
Table 115. MSD Corporation Information
Table 116. MSD Description and Business Overview
Table 117. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. MSD Follicle Stimulating Hormone Product
Table 119. MSD Recent Development
Table 120. IBSA Corporation Information
Table 121. IBSA Description and Business Overview
Table 122. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. IBSA Follicle Stimulating Hormone Product
Table 124. IBSA Recent Development
Table 125. Ferring Corporation Information
Table 126. Ferring Description and Business Overview
Table 127. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Ferring Follicle Stimulating Hormone Product
Table 129. Ferring Recent Development
Table 130. Livzon Corporation Information
Table 131. Livzon Description and Business Overview
Table 132. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Livzon Follicle Stimulating Hormone Product
Table 134. Livzon Recent Development
Table 135. Techwell Corporation Information
Table 136. Techwell Description and Business Overview
Table 137. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Techwell Follicle Stimulating Hormone Product
Table 139. Techwell Recent Development
Table 140. GenSci Corporation Information
Table 141. GenSci Description and Business Overview
Table 142. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. GenSci Follicle Stimulating Hormone Product
Table 144. GenSci Recent Development
Table 145. Gedeon Richter Corporation Information
Table 146. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Gedeon Richter Description and Business Overview
Table 148. Gedeon Richter Follicle Stimulating Hormone Product
Table 149. Gedeon Richter Recent Development
Table 150. Teva Corporation Information
Table 151. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Teva Description and Business Overview
Table 153. Teva Follicle Stimulating Hormone Product
Table 154. Teva Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Follicle Stimulating Hormone Distributors List
Table 158. Follicle Stimulating Hormone Customers List
Table 159. Follicle Stimulating Hormone Market Trends
Table 160. Follicle Stimulating Hormone Market Drivers
Table 161. Follicle Stimulating Hormone Market Challenges
Table 162. Follicle Stimulating Hormone Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicle Stimulating Hormone Product Picture
Figure 2. Global Follicle Stimulating Hormone Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Follicle Stimulating Hormone Sales Market Share by Application in 2021 & 2027
Figure 6. Infertility Treatment Examples
Figure 7. Assisted Reproductive Technology Examples
Figure 8. Global Follicle Stimulating Hormone Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Follicle Stimulating Hormone Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global Follicle Stimulating Hormone Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global Follicle Stimulating Hormone Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Follicle Stimulating Hormone Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Follicle Stimulating Hormone Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Follicle Stimulating Hormone Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Follicle Stimulating Hormone Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Follicle Stimulating Hormone Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Follicle Stimulating Hormone Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Follicle Stimulating Hormone Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Follicle Stimulating Hormone Players Market Share by Revenue in Follicle Stimulating Hormone: 2016 & 2020
Figure 27. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Follicle Stimulating Hormone Revenue Share by Type (2016-2021)
Figure 29. Global Follicle Stimulating Hormone Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Follicle Stimulating Hormone Revenue Share by Application (2016-2021)
Figure 31. Global Follicle Stimulating Hormone Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 33. North America Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 34. Europe Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 35. Europe Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 36. China Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 37. China Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 38. Japan Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 39. Japan Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 40. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 41. Southeast Asia Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 42. India Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 43. India Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Follicle Stimulating Hormone
Figure 46. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 47. Follicle Stimulating Hormone Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed